drugset / Trial / NCT03834012

Beclomethasone Dipropionate HFA in Adult and Adolescent Subjects With Persistent Asthma

NCT03834012

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Approximately 480 (120 per group) would need to complete the 6 weeks of treatments.

Timeline

Start
2019-02
Primary completion
2019-11
Completion
2020-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Beclomethasone Small molecule 400 ug Inhaled
Subject Beclomethasone Small molecule 640 ug Inhaled
Subject Beclomethasone Small molecule 800 ug Inhaled

Indications